People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Health Care, Healthtech, Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2011 |
| Inspire Medical Systems, Inc. | — | Healthtech | Series B | $52.5M | $309.8M | 2014 |
| XII Medical, Inc. | — | Healthtech | Series B | $45.1M | $146.0M | 2021 |
| Axoft, Inc. | — | Biotechnology | Series A | $9.3M | $3.1M | 2022 |
| Celero Systems, Inc. | — | Software / Tech | Seed | $3.0M | $102.2M | 2019 |
Benjamin Pless at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin Pless on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Casey Tansey | 1 | 14 |
| Rishi Gupta | 1 | 12 |
| Nael Kassar | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| Duke Rohlen | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Aftab Kherani | 1 | 9 |
| Joyce Erony | 1 | 8 |
| James Blair | 1 | 8 |
| Greg Garfield | 1 | 8 |
| Dana Mead | 1 | 7 |
| David Fischell | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Carlo Giovanni Traverso | 1 | 6 |
| Tony Natale | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Evan Norton | 1 | 4 |
| Brad Vale | 1 | 4 |
| Joseph Lacob | 1 | 4 |
| Mudit Jain | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.